Surgeon Laura Esserman to receive tribute from nationwide organization.
The American Cancer Society will pay tribute to Laura Esserman, M.D., M.B.A., an internationally known leader in the field of breast cancer care and research.
A surgeon and 20-year member of the faculty at UC San Francisco, Esserman is leading an effort to change the delivery of breast cancer services and the information systems used to support both research and patient care.
She will be honored Tuesday (March 19) at the Four Seasons Hotel in San Francisco. Established in 1913, the American Cancer Society is a nationwide voluntary health organization dedicated to eliminating cancer.
As a professor of surgery and radiology, Esserman co-leads the Breast Oncology Program and serves as associate director of the UCSF Helen Diller Family Comprehensive Cancer Center.
She is a member of President Obama’s Council of Advisors on Science and Technology (PCAST) Working Group on Advancing Innovation in Drug Development and Evaluation, which is studying how the federal government can best support science-based innovation in the process of drug development and regulatory evaluation.
Esserman has worked at UCSF to develop interdisciplinary teams of clinicians and researchers to bring the best care to patients and find the best platform to integrate translational research and improve the delivery of breast cancer care.
Director of the Carol Franc Buck Breast Care Center at UCSF, she is founder and faculty leader of the program in Translational Informatics spanning the disciplines of bioinformatics, medical and clinical informatics, systems integration, and clinical care delivery.
Esserman is the principle investigator of the I-SPY TRIAL program, a multisite neoadjuvant clinical trial that has evolved into a model for translational research and innovation in clinical trial design. I-SPY combines personalized medicine with a novel investigational design to identify women at high risk of early breast cancer recurrence. It is under way at 19 major cancer centers around the country.
Esserman has recently launched a University of California-wide breast cancer initiative called the Athena Breast Health Network, a groundbreaking project designed to follow 150,000 women from screening through treatment and outcomes, incorporating the latest in molecular testing and Web-based tools into the course of care.